{"schema_version":"secwatch.filing_event.v1","accession":"0001764013-23-000026","form_type":"8-K","ticker":"IMVT","cik":"0001764013","company_name":"Immunovant, Inc.","filed_at":"2023-03-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.458375+00:00","generated_at":"2026-06-17T15:18:18.358075+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Immunovant files 8-K with corporate presentation; no material updates disclosed in filing or exhibit text.","bullets":["Immunovant released a new corporate presentation for investor business updates on March 27, 2023.","No financial results, clinical data, or guidance changes are included in the 8-K or its sole exhibit (cover page only).","The presentation content is not fully reproduced; material updates, if any, are not evident from the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001764013-23-000026","json":"https://secwatch.observer/filing/0001764013-23-000026.json","markdown":"https://secwatch.observer/filing/0001764013-23-000026.md","text":"https://secwatch.observer/filing/0001764013-23-000026.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1764013/000176401323000026/0001764013-23-000026-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1764013/000176401323000026/imvt-20230327.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T15:18:18.358075+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}